152 related articles for article (PubMed ID: 7808020)
1. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994; 8 Suppl 3():S22-5. PubMed ID: 7808020
[TBL] [Abstract][Full Text] [Related]
2. Clinical and pharmacokinetic studies of all-trans-retinoic acid in pediatric patients with cancer.
Adamson PC
Leukemia; 1994 Nov; 8(11):1813-6. PubMed ID: 7967727
[TBL] [Abstract][Full Text] [Related]
3. Phase I trial and pharmacokinetic study of all-trans-retinoic acid administered on an intermittent schedule in combination with interferon-alpha2a in pediatric patients with refractory cancer.
Adamson PC; Reaman G; Finklestein JZ; Feusner J; Berg SL; Blaney SM; O'Brien M; Murphy RF; Balis FM
J Clin Oncol; 1997 Nov; 15(11):3330-7. PubMed ID: 9363862
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacokinetic studies of all-trans retinoic acid (ATRA) and pilot study of intermittent schedule of ATRA and chemotherapy in childhood acute promyelocytic leukemia. Children's Cancer and Leukemia Study Group].
Hirota T; Fujimoto T; Konno K; Sakakibara Y; Katano N; Tsurusawa M; Takitani K; Miyake M
Rinsho Ketsueki; 1997 Nov; 38(11):1170-6. PubMed ID: 9423333
[TBL] [Abstract][Full Text] [Related]
5. Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein.
Adamson PC; Boylan JF; Balis FM; Murphy RF; Godwin KA; Gudas LJ; Poplack DG
Cancer Res; 1993 Feb; 53(3):472-6. PubMed ID: 8381046
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of all-trans-retinoic acid in children with acute promyelocytic leukemia.
Lanvers C; Reinhardt D; Dübbers A; Wagner-Bohn A; Creutzig U; Ritter J; Boos J
Med Pediatr Oncol; 2003 May; 40(5):293-301. PubMed ID: 12652617
[TBL] [Abstract][Full Text] [Related]
7. Retinoids in pediatric onco-hematology: the model of acute promyelocytic leukemia and neuroblastoma.
Masetti R; Biagi C; Zama D; Vendemini F; Martoni A; Morello W; Gasperini P; Pession A
Adv Ther; 2012 Sep; 29(9):747-62. PubMed ID: 22941525
[TBL] [Abstract][Full Text] [Related]
8. Retinoid therapy of childhood cancer.
Reynolds CP; Lemons RS
Hematol Oncol Clin North Am; 2001 Oct; 15(5):867-910. PubMed ID: 11765378
[TBL] [Abstract][Full Text] [Related]
9. Phase I trial of all-trans retinoic acid in patients with treated head and neck squamous carcinoma.
Park SH; Gray WC; Hernandez I; Jacobs M; Ord RA; Sutharalingam M; Smith RG; Van Echo DA; Wu S; Conley BA
Clin Cancer Res; 2000 Mar; 6(3):847-54. PubMed ID: 10741706
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of all-trans-retinoic acid in hormone-refractory prostate cancer: a clinical trial with detailed pharmacokinetic analysis.
Trump DL; Smith DC; Stiff D; Adedoyin A; Day R; Bahnson RR; Hofacker J; Branch RA
Cancer Chemother Pharmacol; 1997; 39(4):349-56. PubMed ID: 9025776
[TBL] [Abstract][Full Text] [Related]
11. A phase I trial and pharmacokinetic study of 9-cis-retinoic acid (ALRT1057) in pediatric patients with refractory cancer: a joint Pediatric Oncology Branch, National Cancer Institute, and Children's Cancer Group study.
Adamson PC; Widemann BC; Reaman GH; Seibel NL; Murphy RF; Gillespie AF; Balis FM
Clin Cancer Res; 2001 Oct; 7(10):3034-9. PubMed ID: 11595692
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat.
Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M
Br J Cancer; 2001 Dec; 85(12):2004-9. PubMed ID: 11747346
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of intravenously administered liposomal all-trans-retinoic acid (ATRA) and orally administered ATRA in healthy volunteers.
Ozpolat B; Lopez-Berestein G; Adamson P; Fu CJ; Williams AH
J Pharm Pharm Sci; 2003; 6(2):292-301. PubMed ID: 12935441
[TBL] [Abstract][Full Text] [Related]
14. Phase I and pharmacokinetic evaluation of all-trans-retinoic acid in pediatric patients with cancer.
Smith MA; Adamson PC; Balis FM; Feusner J; Aronson L; Murphy RF; Horowitz ME; Reaman G; Hammond GD; Fenton RM
J Clin Oncol; 1992 Nov; 10(11):1666-73. PubMed ID: 1403049
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and clinical impact of all-trans retinoic acid in metastatic breast cancer: a phase II trial.
Sutton LM; Warmuth MA; Petros WP; Winer EP
Cancer Chemother Pharmacol; 1997; 40(4):335-41. PubMed ID: 9225952
[TBL] [Abstract][Full Text] [Related]
16. Phase I/II trial of all-trans retinoic acid and tamoxifen in patients with advanced breast cancer.
Budd GT; Adamson PC; Gupta M; Homayoun P; Sandstrom SK; Murphy RF; McLain D; Tuason L; Peereboom D; Bukowski RM; Ganapathi R
Clin Cancer Res; 1998 Mar; 4(3):635-42. PubMed ID: 9533531
[TBL] [Abstract][Full Text] [Related]
17. Phase I trial of oral fenretinide in children with high-risk solid tumors: a report from the Children's Oncology Group (CCG 09709).
; Villablanca JG; Krailo MD; Ames MM; Reid JM; Reaman GH; Reynolds CP
J Clin Oncol; 2006 Jul; 24(21):3423-30. PubMed ID: 16849757
[TBL] [Abstract][Full Text] [Related]
18. The Challenge of Developing New Therapies for Childhood Cancers.
Balis FM
Oncologist; 1997; 2(1):I-II. PubMed ID: 10388032
[TBL] [Abstract][Full Text] [Related]
19. All trans retinoic acid and cancer.
Siddikuzzaman ; Guruvayoorappan C; Berlin Grace VM
Immunopharmacol Immunotoxicol; 2011 Jun; 33(2):241-9. PubMed ID: 20929432
[TBL] [Abstract][Full Text] [Related]
20. Phase I study of 9-cis-retinoic acid (ALRT1057 capsules) in adults with advanced cancer.
Rizvi NA; Marshall JL; Ness E; Yoe J; Gill GM; Truglia JA; Loewen GR; Jaunakais D; Ulm EH; Hawkins MJ
Clin Cancer Res; 1998 Jun; 4(6):1437-42. PubMed ID: 9626460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]